The percentage of Baycol patients who got Lopid, too, dropped from 63% to 62%.
The company is still stumbling from the recall of the key cholesterol drug Baycol.
In December 1999, Bayer changed the labeling on Baycol to warn of the Lopid drug interaction.
One similar medication, Bayer's Baycol, was taken off the market due to lethal side effects.
Among the statins we have seen differences in safety profiles that led Baycol to be recalled.
FORBES: AstraZeneca Study is Good News for the Public, Bad News for AstraZeneca
It had to recall its cholesterol drug Baycol, in 2001, to fight off a bevy of lawsuits.
There would be nothing to stop Bayer from selling the pharmaceutical business without the potential Baycol liabilities.
Bayer might have made a fatal mistake when it decided to release a higher-dose version of Baycol.
Bayer was forced to recall Baycol, leading to speculation that its drug division cannot survive on its own.
This summer, it had to recall its cholesterol treatment, Baycol, after the drug was linked to dozens of deaths.
Even before the Baycol fiasco, the company had a big problem: its drug pipeline has been anemic at best.
The shares lost 27% of their value after the withdrawal of Baycol and are down 36% in a year.
Certainly the Baycol situation has put a lot more focus on muscle safety.
The drug division is unlikely to remain profitable as a separate entity, with Baycol gone and only a skimpy near-term drug pipeline.
Take, for instance, the 1999 label change for Baycol, a cholesterol drug from Bayer that has since been withdrawn from the market.
Big, headline-grabbing drug withdrawals that affect millions of patients, like those of Baycol, Vioxx, and Zelnorm, could become a thing of the past.
The new label warned that giving Baycol with Lopid, a Pfizer cholesterol drug, substantially increased the likelihood of potentially dangerous muscle side effects.
The Food and Drug Administration warned in 1999 that combining the cholesterol drugs Baycol and Lopid increased the risk of deadly muscle side effects.
These side effects resulted in one entrant, Bayer 's (nyse: BAY - news - people ) Baycol, being withdrawn from the market.
The matter became urgent last month following Bayer's withdrawal of an anti-cholesterol drug, marketed under the name Lipobay in Germany and Baycol almost everywhere else.
The percentage of reported rhabdomyolysis patients who had taken both Baycol and Lopid shifted from 63% in the months before the warning to 62% in the months afterward.
One statin, Baycol from Bayer, was withdrawn as a result.
FORBES: FDA Limits High-Dose Zocor, Backing Earlier Concerns For Second-Most Prescribed Drug
Meanwhile, in a filing with the Securities and Exchange Commission, the German company revealed that its cholesterol drug Baycol is linked to 100 deaths--nearly twice as many as previously estimated.
These side effects can be potentially lethal and resulted in one drug, Bayer 's (nyse: BAY - news - people ) Baycol, being withdrawn from the market.
Baycol, a statin made by Bayer (nyse: BAY - news - people ), was recalled after dozens of people died worldwide as a result of such side effects.
Baycol, a variant developed by Bayer (nyse: BAY - news - people ), was withdrawn from the market after it was found that it caused dozens of deaths.
Take, for instance, the 1999 label change for Baycol, a cholesterol drug from Bayer (nyse: BAY - news - people ) that has since been withdrawn from the market.
The new label warned that giving Baycol with Lopid, a Pfizer (nyse: PFE - news - people ) cholesterol drug, substantially increased the likelihood of potentially dangerous muscle side effects.
But now things look so grim that Bayer may have to partner off or sell its drug business, which is flailing after the recall of Baycol, a cholesterol drug linked to 50 deaths worldwide.
Baycol, a statin once sold by Bayer (nyse: BAY - news - people ), was pulled from the market after muscle damage caused kidney problems and death in dozens of patients.
应用推荐